<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01460563</url>
  </required_header>
  <id_info>
    <org_study_id>Mg_orfil</org_study_id>
    <nct_id>NCT01460563</nct_id>
  </id_info>
  <brief_title>Valproic Acid, Magnesium Sulphate, Rocuronium Requirement, Postoperative Analgesia</brief_title>
  <official_title>Effects of Valproic Acid and Magnesium Sulphate on Rocuronium Requirement and Postoperative Analgesia in Patients Undergoing Craniotomy for Cerebrovascular Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesized that valproic acid will increase rocuronium requirement and
      MgSO4 infusion would reduce requirement of muscle relaxant in craniotomy patients preloaded
      with sodium valproate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Magnesium sulfate (MgSO4) is known to reduce requirement of muscle relaxant.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rocuronium</measure>
    <time_frame>participants will be followed for the duration of the surgery, an expected average of 5.5 hours.</time_frame>
    <description>Roc 0.15mg/kg is injected when train of four (TOF) becomes 2 which is measured with TOF-watch Sx. The total amount of Roc that injected is recorded.
The intervals of each Roc 0.15mg/kg injection will also be recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hemodynamics</measure>
    <time_frame>participants will be followed for the duration of the surgery, an expected average of 5.5 hours; postoperative 24 hour; postoperative 48 hour</time_frame>
    <description>mean arterial pressure and heart rate is measured for the duration of the surgery, an expected average of 5.5 hours; postoperative 24 hour; postoperative 48 hour.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total amount of anesthetics</measure>
    <time_frame>participants will be followed at the end of the surgery, an expected average of 5.5 hours after induction of anesthesia..</time_frame>
    <description>total amount of propofol and remifentanil infused is measured.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Magnesium concentration</measure>
    <time_frame>from the induction of anesthesia until end of the surgery</time_frame>
    <description>serum Magnesium concentration is measured just prior to anesthetic drug administration, 3 hour after the induction of anesthesia, and at the end of the surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effects</measure>
    <time_frame>participants will be followed for the duration of the surgery, an expected average of 5.5 hours; postoperative 24 hour; postoperative 48 hour.</time_frame>
    <description>complicaton associated with MgSO4 including muscle weakness, hot flush, and nausea/ vomiting.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain, nausea &amp; vomiting, analgesics use, antiemetics use, nicardipine use</measure>
    <time_frame>patients will be followed from the end of the operation until postoperativ 48 h</time_frame>
    <description>Pain will be assessed using numeric rating scale at 6 h, 24 h, and 48 h postoperately.
Cumulative dose of analgesics and nicardipine, incidence of nicardipine and antiemtics use during 48h postoperatively will be recorded.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cerebral Aneurysm</condition>
  <arm_group>
    <arm_group_label>Mg_orfil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients preloaded with sodium valproate receives MgSO4 during the craniotomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control_orfil</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients preloaded with sodium valproate receives 0.9% saline as placebo.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control_no orfil</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients not preloaded with sodium valproate receives 0.9% saline as placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>MgSO4 infusion: 50mg/kg bolus followed by continuous infusion</description>
    <arm_group_label>Mg_orfil</arm_group_label>
    <other_name>MgSO4</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% saline</intervention_name>
    <description>0.9% saline as same dose as MgSO4 as placebo</description>
    <arm_group_label>control_orfil</arm_group_label>
    <other_name>NaCl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% saline</intervention_name>
    <description>0.9% saline as same dose as MgSO4 as placebo</description>
    <arm_group_label>control_orfil</arm_group_label>
    <arm_group_label>control_no orfil</arm_group_label>
    <other_name>NaCl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18- 65 years

          -  American society of anesthesiology physical status 1,2

          -  scheduled for elective craniotomy for aneurysm clipping or for superficial temporal
             artery-middle cerebral artery anastomosis

        Exclusion Criteria:

        body mass index &lt;18.5 or &gt;24.9 kg m-2; neuromuscular, renal, cardiovascular or hepatic
        insufficiency; Glasgow coma scale (GCS) &lt;15; allergy to the study drugs; medications
        influencing NDMRs; breast feeding; pregnancy; and preoperative epilepsy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanghwan Do, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mihyun Kim, Doctor</last_name>
    <phone>82-31-787-7499</phone>
    <email>snmd56@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang hopital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-Do</state>
        <zip>463-787</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mihyun Kim, Doctor</last_name>
      <phone>82-31-787-7499</phone>
      <email>snmd56@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2011</study_first_submitted>
  <study_first_submitted_qc>October 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2011</study_first_posted>
  <last_update_submitted>December 26, 2011</last_update_submitted>
  <last_update_submitted_qc>December 26, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 29, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Kim Mihyun</investigator_full_name>
    <investigator_title>clinical professor</investigator_title>
  </responsible_party>
  <keyword>craniotomy</keyword>
  <keyword>sodium valproate</keyword>
  <keyword>rocuronium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Valproic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

